The global antidepressant drugs market is anticipated to grow at a significant CAGR of 3.1% during the forecast period. Product innovations coupled with many leading advancements in antidepressant drugs are anticipated to drive the market in the coming years. For instance, in February 2022, Sage Therapeutics and Biogen announced that the phase 3 CORAL study met its primary and key secondary endpoints comparing Zuranolone 50 mg co-initiated with the standard of care antidepressant vs. standard of care co-initiated with Placebo in People with MDD. This will significantly help in the reduction of depression symptoms in people.  

Global vaso occlusive crisis associated with sickle cell disease market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028).  The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in September 2019, the US Government and Gates Foundation have pledged $200 million to bring gene therapy to patients with sickle diseases. 

The global end-stage kidney disease treatment market is anticipated to grow at considerable CAGR during the forecast period (2022-2028). Key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in January 2019, Fresenius Medical Care has launched a 4008A dialysis machine. The purpose of the launch was to improve the accessibility of high-standard dialysis treatment to patients who are suffering from end-stage kidney diseases with high-standard therapies while reducing the cost of health care systems

The global flunarizine hydrochloride market is anticipated to grow at considerable CAGR during the forecast period (2022-2028). Rise in the prevalence of the aging population associated with vertigo is expected to drive the global flunarizine hydrochloride market. For instance, according to the data published by National Center for Biotechnology Information (NCBI) in 2021, Vertigo increases with the prevalence of age and other underlying diseases. Based on a survey on the general population, the 1-year prevalence of vertigo is about 5 % and the annual incidence is estimated at 1.4 %. Moreover, dizziness in vertigo is another major factor affecting the population. 

The global transdermal patches market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The market is expected to increase, owing to the efficacy of transdermal patches in addressing difficulties and growing applications. Transdermal Patches are a type of patch that adheres to the skin and delivers medication to the body through it. It does not use sirens or other materials that must be injected into the body, however, instead uses glue that adheres to the skin, making it simple to put and remove. 

The global kidney cancer drugs market is anticipated to grow at a considerable CAGR during the forecast years. A major factor that drives the global kidney cancer drug market due to the increasing prevalence of kidney cancer which exacerbates the need for kidney cancer treatment.

The global Omega product market is anticipated to grow at a considerable CAGR of 7.9% during the forecast period (2022-2028). The market can see considerable growth during the forecast period as with the increasing population especially pregnant women in many parts of the world. Omega 3 supplement is a necessity in the baby and infant food products. Studies show that Docosahexaenoic Acid, a type of omega 3 helps in the progressive growth of the brain in infants which they need during the initial years after birth. In the initial years after birth, they need a complete diet that is rich in protein, antioxidants, and omega 3.

The global familial adenomatous polyposis treatment market is anticipated to grow at a significant CAGR of 13.9 % during the forecast period. According to the National Cancer Institute trial investigates on obeticholic acid (OCA) is safe and has a beneficial effect on the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is a rare gene defect that increases the risk of developing cancer of the intestines and colon. 

The global catenin beta market is anticipated to grow at a considerable CAGR of around  5 % during the forecast years (2022-2028). Also known as beta-catenin 1, catenin beta is a protein encoded by CTNNB1 in humans. It has various functions including regulation and coordination of cells, cell adhesion, and gene transcription. The major factor driving the growth of the global catenin market is its application in the rising prevalence of dermatological problems including vitiligo. 

The bone marrow transplant rejection treatment market is expected to grow at a significant CAGR during the forecast period(2022-2028). The market for bone marrow transplant is growing due to awareness about organ donation among people due to increased prevalence rates, an increasing number of bone marrow transplant procedures in developed and developing countries are some factors driving the growth of the bone marrow transplant rejection treatment.